CN87108027A - 咪唑并吡啶化合物及其制备方法 - Google Patents

咪唑并吡啶化合物及其制备方法 Download PDF

Info

Publication number
CN87108027A
CN87108027A CN198787108027A CN87108027A CN87108027A CN 87108027 A CN87108027 A CN 87108027A CN 198787108027 A CN198787108027 A CN 198787108027A CN 87108027 A CN87108027 A CN 87108027A CN 87108027 A CN87108027 A CN 87108027A
Authority
CN
China
Prior art keywords
methyl
formula
rudimentary
amino
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198787108027A
Other languages
English (en)
Chinese (zh)
Inventor
塩川洋一
长野正信
井谷弘道
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of CN87108027A publication Critical patent/CN87108027A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN198787108027A 1986-11-26 1987-11-26 咪唑并吡啶化合物及其制备方法 Pending CN87108027A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB8628262 1986-11-26
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds
GB8723439 1987-10-06

Publications (1)

Publication Number Publication Date
CN87108027A true CN87108027A (zh) 1988-06-08

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198787108027A Pending CN87108027A (zh) 1986-11-26 1987-11-26 咪唑并吡啶化合物及其制备方法

Country Status (13)

Country Link
US (1) US4831041A (enExample)
EP (1) EP0268989B1 (enExample)
KR (1) KR880006237A (enExample)
CN (1) CN87108027A (enExample)
AU (1) AU8169387A (enExample)
DE (1) DE3780263T2 (enExample)
DK (1) DK608887A (enExample)
ES (1) ES2064310T3 (enExample)
FI (1) FI875157A7 (enExample)
GR (1) GR3005685T3 (enExample)
HU (1) HUT45526A (enExample)
IL (1) IL84522A0 (enExample)
NO (1) NO874904L (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
EP0370056A1 (de) * 1987-07-16 1990-05-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue diazole
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
EP0471236B1 (en) * 1990-07-30 1995-03-15 Takeda Chemical Industries, Ltd. Imidazopyridine derivatives and their use
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
CZ22697A3 (en) * 1994-07-28 1997-07-16 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinone derivatives, process of their preparation and pharmaceutical composition containing thereof
JPH10505330A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング ハロゲンイミダゾピリジン
AU700737B2 (en) * 1994-07-28 1999-01-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridines
EP0882048B1 (de) * 1996-01-26 2005-05-04 ALTANA Pharma AG 3-alkylimidazopyridine
WO1997027193A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
CA3142817A1 (en) * 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EP3919056B1 (en) 2013-03-15 2024-08-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN112500338A (zh) 2013-03-15 2021-03-16 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
EP2968299B1 (en) 2013-03-15 2021-01-20 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SG10201911662YA (en) 2014-02-07 2020-02-27 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
HUE072191T2 (hu) 2015-12-04 2025-10-28 Global Blood Therapeutics Inc A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje
TWI825524B (zh) 2016-05-12 2023-12-11 美商全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
NO874904D0 (no) 1987-11-25
DK608887A (da) 1988-05-27
DE3780263T2 (de) 1992-12-24
DK608887D0 (da) 1987-11-19
IL84522A0 (en) 1988-04-29
EP0268989A1 (en) 1988-06-01
GR3005685T3 (enExample) 1993-06-07
DE3780263D1 (de) 1992-08-13
EP0268989B1 (en) 1992-07-08
AU8169387A (en) 1988-06-02
US4831041A (en) 1989-05-16
HUT45526A (en) 1988-07-28
ES2064310T3 (es) 1995-02-01
FI875157A7 (fi) 1988-05-27
KR880006237A (ko) 1988-07-22
NO874904L (no) 1988-05-27
FI875157A0 (fi) 1987-11-23

Similar Documents

Publication Publication Date Title
CN87108027A (zh) 咪唑并吡啶化合物及其制备方法
CN1033088C (zh) 新的噻唑基苯并呋喃衍生物的制备方法
CN1193018C (zh) 杂环衍生物及其医药用途
CN1031570C (zh) 吡唑并吡啶化合物的制备方法
CN1034869C (zh) 肽类化合物及其可药用盐的制备方法
CN1022187C (zh) 三环化合物的制备方法
CN1033628A (zh) 咪唑并吡啶类化合物及其制备方法
CN1067886A (zh) 新的脲衍生物,它们的制备方法及其药物组合物
CN1017242B (zh) 新的喹唑啉衍生物的制备方法
CN1209809A (zh) 新化合物
CN1157617A (zh) 杂双环衍生物
CN86104313A (zh) 咪唑并杂环化合物的制备方法
CN1049337A (zh) 噻唑衍生物,制备它们的方法,以及含有它们的药用组合物
CN87105680A (zh) 咪唑化合物及其制备方法,和包含该化合物的药物组合物
CN1168667A (zh) 用作缓激肽拮抗剂的吡啶并嘧啶酮,喹啉和稠合的n-杂环化合物
CN1060848A (zh) 肽类化合物、其制法和其药物组合物
CN86108205A (zh) 新的噻唑化合物及其制备方法和它们的药物组合物
CN1106007A (zh) 新的磺酰氨基嘧啶类化合物
CN1042905A (zh) 2(1h)喹啉酮化合物及其药用组合物的制备方法
CN1100417A (zh) N-杂芳基-n'-苯脲衍生物及其生产和应用
CN86100964A (zh) 哌啶化合物的制备方法
CN86107947A (zh) 新的头孢烯化合物及其制备方法
CN1021733C (zh) 制备新的吲哚基哌啶类化合物的方法
CN1087639A (zh) 杂三环衍生物
CN87107990A (zh) 新颖的苯并噻二嗪,其制备方法及其药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication